DK1090915T3 - Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on - Google Patents

Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on

Info

Publication number: DK1090915T3
Authority: DK; Denmark
Prior art keywords: cyclopropylmethoxy; methylsulfonyl; polymorphic; dimethyl; furan
Prior art date: 1999-10-08

Application number

DK99402482T

Other languages

English (en)

Inventor

Beatrice Calais

Evelyne Chassagneux

Jean-Michel Bonard

Original Assignee

Merial Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-08

Filing date

1999-10-08

Publication date

2009-07-13

1999-10-08 Application filed by Merial Sas filed Critical Merial Sas

2009-07-13 Application granted granted Critical

2009-07-13 Publication of DK1090915T3 publication Critical patent/DK1090915T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Pregnancy & Childbirth (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)

DK99402482T 1999-10-08 1999-10-08 Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on DK1090915T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99402482A EP1090915B1 (en)	1999-10-08	1999-10-08	Polymorphic B form of 3-(cyclopropylmethoxy)-4-¬-4-(methylsulfonyl)phenyl - 5,5-dimethyl-5H-furan-2-one

Publications (1)

Publication Number	Publication Date
DK1090915T3 true DK1090915T3 (da)	2009-07-13

Family

ID=8242136

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99402482T DK1090915T3 (da)	1999-10-08	1999-10-08	Polymorphic B form af 3-(cyclopropylmethoxy)-4--4-(methylsulfonyl)phenyl- 5,5-dimethyl-5H-furan-2-on

Country Status (12)

Country	Link
US (1)	US6677373B2 (da)
EP (1)	EP1090915B1 (da)
JP (1)	JP4805505B2 (da)
AT (1)	ATE432269T1 (da)
AU (2)	AU774172C (da)
CA (1)	CA2386549C (da)
CY (1)	CY1110062T1 (da)
DE (1)	DE69940922D1 (da)
DK (1)	DK1090915T3 (da)
ES (1)	ES2326849T3 (da)
PT (1)	PT1090915E (da)
WO (1)	WO2001027097A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005049794A2 (en)	2003-11-13	2005-06-02	University Of Georgia Research Foundation, Inc.	Methods of characterizing infectious bursal disease virus
US7151158B2 (en) *	2004-01-30	2006-12-19	General Electric Company	Method of preparing a poly(arylene ether), apparatus therefor, and poly(arylene ether) prepared thereby
US7862821B2 (en)	2006-06-01	2011-01-04	Merial Limited	Recombinant vaccine against bluetongue virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5474995A (en) *	1993-06-24	1995-12-12	Merck Frosst Canada, Inc.	Phenyl heterocycles as cox-2 inhibitors
UA57002C2 (uk) *	1995-10-13	2003-06-16	Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі.	Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
WO1997016435A1 (en) *	1995-10-30	1997-05-09	Merck Frosst Canada Inc.	3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
AU710675B2 (en) *	1996-02-01	1999-09-30	Merck Frosst Canada Ltd.	Alkylated styrenes as prodrugs to COX-2 inhibitors
JP2001514668A (ja) *	1997-03-14	2001-09-11	メルクフロストカナダアンドカンパニー	Ｃｏｘ−２阻害薬としての酸素連結部を有する（メチルスルホニル）フェニル−２−（５ｈ）−フラノン類

1999
- 1999-10-08 DK DK99402482T patent/DK1090915T3/da active
- 1999-10-08 PT PT99402482T patent/PT1090915E/pt unknown
- 1999-10-08 EP EP99402482A patent/EP1090915B1/en not_active Expired - Lifetime
- 1999-10-08 DE DE69940922T patent/DE69940922D1/de not_active Expired - Lifetime
- 1999-10-08 ES ES99402482T patent/ES2326849T3/es not_active Expired - Lifetime
- 1999-10-08 AT AT99402482T patent/ATE432269T1/de active
2000
- 2000-10-09 JP JP2001530316A patent/JP4805505B2/ja not_active Expired - Lifetime
- 2000-10-09 AU AU79218/00A patent/AU774172C/en not_active Expired
- 2000-10-09 CA CA2386549A patent/CA2386549C/en not_active Expired - Lifetime
- 2000-10-09 WO PCT/EP2000/010421 patent/WO2001027097A1/en not_active Ceased
2002
- 2002-04-08 US US10/117,854 patent/US6677373B2/en not_active Expired - Lifetime
2004
- 2004-08-31 AU AU2004206979A patent/AU2004206979A1/en not_active Abandoned
2009
- 2009-08-24 CY CY20091100891T patent/CY1110062T1/el unknown

Also Published As

Publication number	Publication date
CA2386549C (en)	2010-09-21
EP1090915B1 (en)	2009-05-27
AU774172B2 (en)	2004-06-17
DE69940922D1 (de)	2009-07-09
ES2326849T3 (es)	2009-10-20
EP1090915A1 (en)	2001-04-11
AU774172C (en)	2005-06-09
ATE432269T1 (de)	2009-06-15
JP4805505B2 (ja)	2011-11-02
AU2004206979A1 (en)	2004-09-30
CA2386549A1 (en)	2001-04-19
AU7921800A (en)	2001-04-23
US6677373B2 (en)	2004-01-13
US20030050337A1 (en)	2003-03-13
WO2001027097A1 (en)	2001-04-19
JP2003511443A (ja)	2003-03-25
CY1110062T1 (el)	2015-01-14
PT1090915E (pt)	2009-08-03

Publication	Publication Date	Title
MA27349A1 (fr)	2005-06-01	Composition cristalline renfermant de l'escitalopram.
DE69803907D1 (de)	2002-03-28	Fungizide 2-Methoxybenzophenone
NO920767L (no)	1992-08-28	Pyranylcyanoguanidin-derivater
IL98378A0 (en)	1992-07-15	Substituted phthalides and heterocyclic phthalides,their preparation and their use as herbicides
AU8052901A (en)	2002-01-30	Methods of synthesizing an oxidant and applications thereof
ID30160A (id)	2001-11-08	Penggunaan 3-(2,4,6 trimetil) neopentilkarboniloksi 5,5-tetrametilena delta3-dihidrofuran-2-on untuk mengontrol white fly
ATE237612T1 (de)	2003-05-15	Benzofuranderivate
CY1107913T1 (el)	2013-09-04	Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc
DK1100789T3 (da)	2005-05-23	Substituerede benzoylcyclohexandioner
DE59409672D1 (de)	2001-04-12	Festphasensynthese von Oligoribonucleotiden
HRP20030853B1 (en)	2011-11-30	Crystalline form of omeprazole
DK240084D0 (da)	1984-05-15	New beta-carboline-3-oxadiazolyl derivatives
KR950017992A (ko)	1995-07-22	알프조신 염산염의 2수화물
CY1110062T1 (el)	2015-01-14	Πολυμορφικη μορφη β της 3-(κυκλοπροπυλμεθοξυ)4- [ -4-(μεθυλσουλφονυλ)φαινυλ]-5,5-διμεθυλ-5η-φουραν-2-ονης
BR0102430A (pt)	2002-02-19	Precursores de fragrância
DE60101639D1 (de)	2004-02-05	Ein (1'R,2'S,5'R)-3-l-Menthoxypropan-1-ol, das eine kühlende Empfindung erzeugt
FR2805456B1 (fr)	2002-12-06	Prothese totale de genou, du type dit "postero-stabilisee"
DE60006825D1 (de)	2004-01-08	Serotonerge benzofurane
ATE250021T1 (de)	2003-10-15	Hydroxycyclopentanone
DK1240163T3 (da)	2004-06-07	3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
ATE282726T1 (de)	2004-12-15	Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten
BR0113978A (pt)	2003-07-29	Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas
AR026673A1 (es)	2003-02-19	Benzoilpirazoles sustituidos por 3-(4,5-dihidroisoxazol-3-ilo)
EP1049481A4 (en)	2001-09-12	SYNTHETIC ANTINEOPLASTIC ACTIVE SUBSTANCES, DERIVATIVES OF DOLASTATIN 15 AND METHODS OF THEIR PRODUCTION
CY1110529T1 (el)	2015-04-29	Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων